Dr Stock Pick HOT News & Alerts!
_______________________________________
FREE Daily Stock Alerts From DrStockPick.com
_______________________________________
DrStockPick.com Watch List!
My Picks for Wednesday September 16, 2009, are:
**************************************************************
MVIS, Microvision, Inc.
MVIS is a global leader in innovative ultra-miniature projection display and image capture products for mobility applications
Today was the commercial introduction of the world’s first laser-based pico projector, called SHOW WX™, based on its proprietary PicoP® display engine technology.
The MVIS pico projector uses the revolutionary laser-based PicoP display engine that delivers large, colorful, bright, and vivid images that are always in focus, regardless of projection distance. The accessory product is a simple plug-n-play pico projector for people on-the-go who want to spontaneously view and share mobile TV, movies, photos, presentations and more.
More about MVIS at www.microvision.com
**************************************************************
NBIX, Neurocrine Biosciences Inc.
NBIX is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.
The NBIX’s research and development efforts are focused on neurological and endocrine diseases and disorders. Its product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders.
NBIX could receive up to $75 million over a three-year period under terms of an investment deal with private investment firm Kingsbridge Capital Limited, which would provide the capital by purchasing newly-issued shares of Neurocrine common stock.
More about NBIX at www.neurocrine.com
**************************************************************
GVBP, GENova Biotherapeutics Inc., GVBP.OB
GVBP is positioning itself as the world’s leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec.
GVBP has signed a collaboration agreement with Prime BioResearch, Ltd., which is in the business of identifying, evaluating and acquiring potential blockbuster developmental drugs in medical markets with significant growth potential. Prime BioResearch currently has a proprietary portfolio of six worldwide patents in Obesity and Diabetes-II with of $2.9 billion, if successfully brought through development, clinical trials, and to market (Source: PriceWaterhouseCoopers)
Through scientific collaboration in the field of personalized medicines, both companies will expedite their drug development activities and subsequently add hundreds of millions of dollars to the bottom line by licensing the technology to companies like Pfizer, Merck, Eli Lilly, Sanofi, Roche, and GSK.
More about GVBP at www.genovabio.com
**************************************************************
Add MVIS, NBIX and GVBP to your Watch List!, do your homework, and like always BE READY for the ACTION!
***********Advertisement***********
****************************
THIS IS NOT A RECOMMENDATION TO BUY O R SELL ANY SECURITY! Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations.
_______________________________________________________
_______________________________________________________
Dr. Stock Pick is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com email: investor@drstockpick.com
Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com
